CPS Fluidics Acquires Hexano Corp to Expand Its Microfluidics Market Reach

WALLINGFORD, Conn.–(BUSINESS WIRE)–We are happy to announce the successful integration of Hexano Corp into the CPS Fluidics family. Hexano was founded in 2018 with a focus on the manufacturing and prototyping of microfluidic devices.

With this acquisition, we welcome onboard Andre Babineau, founder of Hexano. Andre is a licensed mechanical engineer who has previously worked in plastic injection molding and plastic microfluidics design. His new role at CPS Fluidics will be as VP of Sales. Andre’s market reach and insight will allow us to increase our domestic and international sales outreach of our microfluidic and flow cell manufacturing services.

One of my main drivers to join the CPS Fluidics team is the ability to offer a more tailored and engineered solution for microfluidics. Being able to give design inputs earlier in the cycle will guarantee a better manufacturable product at commercial scale.” – Andre Babineau, Founder of Hexano.

About CPS Fluidics

CPS Fluidics designs, develops, and manufactures a range of custom fluidic products from large scale flow cells to microfluidic devices. We are a B2B contract manufacturer focused on the life sciences sector, guarding your intellectual property at every step. Our clean room manufacturing infrastructure is set up to scale from low volume prototypes all the way to full commercial volumes with dedicated assembly staff for your product. Our technical staff’s diverse skill set enables us to develop custom flow cell and microfluidic technology for any application such as tissue imaging, micro-arrays, analytical chemistry, cell sorting, sequencing, etc. For more information, please visit us at www.cpsfluidics.com

Contacts

Media:
Andre Babineau

1-800-695-0021

[email protected]

Subscribe on LinkedIn

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.